Cotylenin A, a new differentiation inducer, and rapamycin cooperatively inhibit growth of cancer cells through induction of cyclin G2
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-08-10
著者
-
Honma Yoshio
Department Of Life Science Shimane University Faculty Of Medicine
-
Honma Yoshio
School Of Medicine Shimane University
-
OKABE KADO
Research Institute for Clinical Oncology, Saitama Cancer Center
-
Okabe Kado
Research Institute For Clinical Oncology Saitama Cancer Center
-
Kasukabe Takashi
Research Institute For Clinical Oncology Saitama Cancer Center
関連論文
- Extracellular NM23 protein promotes the growth and survival of primary cultured human acute myelogenous leukemia cells
- Extracellular NM23-H1 protein inhibits the survival of primary cultured normal human peripheral blood mononuclear cells and activates the cytokine production
- Clinical significance of serum NM23-H1 protein in neuroblastoma
- Ellagic acid, a natural polyphenolic compound, induces apoptosis and potentiates retinoic acid-induced differentiation of human leukemia HL-60 cells
- Cotylenin A, a new differentiation inducer, and rapamycin cooperatively inhibit growth of cancer cells through induction of cyclin G2
- P-123 SYNTHESIS OF FUSICCOCIN DERIVATIVE AS A DIFFERENTIATION INDUCER
- Therapeutic strategy using phenotypic modulation of cancer cells by differentiation-inducing agents
- Molecular Breeding of a Fungus Producing a Precursor Diterpene Suitable for Semi-Synthesis by Dissection of the Biosynthetic Machinery